Alert: New Earnings Report (11/8/23)-Jazz Pharmaceuticals plc (NASDAQ: JAZZ).
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has reported E.P.S. of $2.33 for its third fiscal quarter (ending September 30) versus $-0.31 for the same period a year ago. Relative to the consensus estimate of $4.93, this […]